Core Viewpoint - Kahn Swick & Foti, LLC has initiated an investigation into ASP Isotopes, Inc. following allegations of misleading investors regarding its nuclear fuel technologies and other operational claims [1][2]. Company Overview - ASP Isotopes is a development stage advanced materials company focused on the production, enrichment, and sale of isotopes [2]. - The company has faced scrutiny for its claims about the viability of its nuclear fuel technologies, particularly regarding its High Assay Low-Enriched Uranium (HALEU) facilities [2]. Allegations and Legal Actions - A report by Fuzzy Panda Research accused ASP Isotopes of misleading investors, stating that the company had never tested its technology on uranium and that its cost estimates and timelines were misleading [2]. - Following these allegations, ASP Isotopes and certain executives were sued in a securities class action lawsuit for failing to disclose material information, violating federal securities laws [3]. - The court has denied the company's motion to dismiss part of the case, allowing the lawsuit to proceed [3]. Investigation Focus - Kahn Swick & Foti's investigation is centered on whether ASP's officers and/or directors breached their fiduciary duties to shareholders or violated state or federal laws [3].